Skip to content
Evidity Health Capital
  • Approach
  • Investment Team
  • Portfolio
  • News
Evidity Health Capital
  • Approach
  • Investment Team
  • Portfolio
  • News

News

Check out the latest news about Evidity Health Capital and our portfolio companies.

header-news-1278x1024
  • All
  • 2021
  • 2022

PreludeDxTM Closes $20 Million in Funding to Advance Growth Initiatives and Development of Its Precision Medicine Portfolio

Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics

Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio

Biotheranostics Announces Inclusion of Breast Cancer Index™ in the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines for Prediction of Benefit from Extended Endocrine Therapy

Hologic to Acquire Biotheranostics, Leader in Molecular Tests for Breast and Metastatic Cancers, for Approximately $230 Million

Get in Touch with Us

New York Office

24 West 40th Street, 17th Floor
New York, NY 10018

Miami Office

1111 Brickell Ave, Suite 1525
Miami, FL 33131

  • Max. file size: 512 MB.

Contact Us

© Evidity Health Capital, 2022
Terms and Conditions